Can we select which patients with small breast cancers should receive adjuvant chemotherapy? Discussion

被引:0
|
作者
Beenken, SW
Iglehart, JD
Wood, WC
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:862 / 862
页数:1
相关论文
共 50 条
  • [31] Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
    Tarantino, P.
    Burstein, H. J.
    Lin, N. U.
    Krop, I. E.
    Winer, E. P.
    Schnitt, S. J.
    Hamilton, E. P.
    Hurvitz, S. A.
    Rugo, H. S.
    Curighano, G.
    Tolaney, S. M.
    ANNALS OF ONCOLOGY, 2022, 33 (03) : 234 - 238
  • [32] Outcome of patients with triple-negative breast cancer who did not receive adjuvant chemotherapy
    Izci, Hava
    Ardui, Jan
    Laenen, Annouschka
    Verdoodt, Freija
    Floris, Giuseppe
    Slembrouck, Laurence
    Vergote, Ignace
    Smeets, Ann
    Van Nieuwenhuysen, Els
    Han, Sileny
    Nevelsteen, Ines
    Weltens, Caroline
    Berteloot, Patrick
    Punie, Kevin
    Wildiers, Hans
    Neven, Patrick
    CANCER RESEARCH, 2020, 80 (04)
  • [33] The strategy to select which thoracic esophageal cancer patients should receive cervical lymph node dissection during esophagectomy
    Y. Shimada
    S. Nagatani
    Z. Li
    Y. Ding
    M. Kondo
    T. Kan
    J. Kaganoi
    G. Watanabe
    M. Imamura
    Annals of Surgical Oncology, 2004, 11 : S81 - S81
  • [34] The strategy to select which thoracic esophageal cancer patients should receive cervical lymph node dissection during esophagectomy
    Shimada, Y
    Nagatani, S
    Li, Z
    Ding, Y
    Kondo, M
    Kan, T
    Kaganoi, J
    Watanabe, G
    Imamura, M
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S81 - S81
  • [35] Can we select patients for adjuvant therapy based on the presence of micro-metastatic disease?
    Oakman, C.
    EJC SUPPLEMENTS, 2010, 8 (03): : 120 - 120
  • [36] Adjuvant chemotherapy in early breast cancer: Are we over-treating patients?
    Mittal, Abhenil
    Batra, Atul
    NATIONAL MEDICAL JOURNAL OF INDIA, 2019, 32 (04): : 230 - +
  • [37] BILCAP-study: Should patients with resected biliary tract cancer really receive adjuvant chemotherapy with capecitabine?
    Manzini, G.
    Klotz, U.
    Hines, I.
    Henne-Bruns, D.
    Kremer, M.
    Kirchner, M.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [38] Histological and molecular markers for pancreatic adenocarcinoma: Can they help us define which patients should receive it?
    Weber, SM
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (03) : 200 - 201
  • [39] Histological and Molecular Markers for Pancreatic Adenocarcinoma: Can They Help Us Define Which Patients Should Receive It?
    Sharon M. Weber
    Annals of Surgical Oncology, 2005, 12 : 200 - 201